CASI Pharmaceuticals, Inc. (CASIF)
OTCMKTS · Delayed Price · Currency is USD
0.1288
-0.0312 (-19.50%)
At close: Sep 25, 2026
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $3.29 million as of September 25, 2026. Its market cap has decreased by -87.29% in one year.
Market Cap
3.29M
Enterprise Value
40.02M
Revenue
20.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.13
ChartMarket Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from 101.76M to 3.29M, a decrease of -96.77%. That is a compound annual growth rate of -10.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 3.29M | -81.17% |
| Dec 31, 2025 | 17.47M | -60.16% |
| Dec 31, 2024 | 43.84M | -54.03% |
| Dec 29, 2023 | 95.38M | 291.63% |
| Dec 30, 2022 | 24.35M | -78.22% |
| Dec 31, 2021 | 111.84M | -69.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pacific Software | 3.75M |
| BioAtla | 2.95M |
| Eastgate Biotech | 2.86M |
| Vaccinex | 2.68M |
| International Stem Cell | 2.64M |
| GPL Holdings | 2.56M |
| Abpro Holdings | 2.48M |
| Bioxytran | 2.44M |